Moreover, particularly as many menopausal women have become concerned about the safety of using prescription ... from hot flashes than another group taking a placebo (dummy) pill.

The drug, approved by the U.S. Food and Drug Administration (FDA) in 2023, can reduce the frequency and severity of hot flashes during ... of women never get a prescription for hormone therapy ...

It was approved for market in May 2023 to treat hot flashes ... the drug was licensed for use in December last year, however ...